{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"43"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"35"}],"title":"Hematologic malignancies"},{"measurements":[{"groupId":"OG000","value":"87"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"15"}],"title":"Kaposi sarcoma"},{"measurements":[{"groupId":"OG000","value":"30"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"32"}],"title":"Solid organ tumor associated with HPV infection"},{"measurements":[{"groupId":"OG000","value":"55"},{"groupId":"OG001","value":"13"},{"groupId":"OG002","value":"55"}],"title":"Solid organ tumors unrelated HPV"},{"measurements":[{"groupId":"OG000","value":"52"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"22"}],"title":"Other"},{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}],"title":"Unknown"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"268"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"159"}],"units":"Participants"}],"description":"For each cancer group listed below, the number of new and existing cases per month will be estimated. The distribution of cancer types will be computed as percentages and compared to the cancer type distribution in the HIV/AIDS Cancer Match (HACM) Study:\n\n1. Solid organ tumors associated with human papillomavirus (HPV) infection\n2. Solid organ tumors unrelated to HPV\n3. Kaposi sarcoma\n4. Hematologic malignancies","groups":[{"description":"Considering or currently receiving cancer treatment\n\nNon-Interventional: Participants will be identified via screening of electronic medical records or institutional databases. All eligible participants will have one visit for the collection of broad demographic and clinical data. Data collection at study visit will occur via survey procedures and/or medical record review.\n\nNon-Interventional Follow-up: Participants initiating or receiving ongoing treatment for their cancer will attend a single follow-up visit to recollect broad demographic and clinical data. Data collection at study visits will occur via survey procedures and/or medical record review.","id":"OG000","title":"New, Primary or Recurrent Disease"},{"description":"This includes cases for which there are no current definitive therapy options for cure (i.e., inoperable) but may be considered for non-standard / non-curative therapies.\n\nNon-Interventional: Participants will be identified via screening of electronic medical records or institutional databases. All eligible participants will have one visit for the collection of broad demographic and clinical data. Data collection at study visit will occur via survey procedures and/or medical record review.\n\nNon-Interventional Follow-up: Participants initiating or receiving ongoing treatment for their cancer will attend a single follow-up visit to recollect broad demographic and clinical data. Data collection at study visits will occur via survey procedures and/or medical record review.","id":"OG001","title":"Metastic or Locally Advanced Cancer"},{"description":"Prior diagnosis (within 5 years), in remission - Not currently on cancer treatment other than ART or maintenance therapy.\n\nNon-Interventional: Participants will be identified via screening of electronic medical records or institutional databases. All eligible participants will have one visit for the collection of broad demographic and clinical data. Data collection at study visit will occur via survey procedures and/or medical record review.","id":"OG002","title":"Prior Cancer"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"Enrollment","title":"Number of Cancers in People With HIV (PWH) Who Present for Care at Domestic AMC Sites","type":"PRIMARY","unitOfMeasure":"Participants"}